Dupixent 300 MG/2 ML pen 2ML

Ended Awarded

Contract number
SPE2DB25FS4LS
Awardee
Awarding agency
Obligated
$46,193

Award facts

Contract value 100% obligated
$46,192.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,781,816 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract, valued at $46,192.93, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Quick answers

Who was awarded contract SPE2DB25FS4LS?

SPE2DB25FS4LS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 2, 2025.

How much is contract SPE2DB25FS4LS worth?

The government has obligated $46,193 on SPE2DB25FS4LS.

Is contract SPE2DB25FS4LS an order under another contract?

Yes. SPE2DB25FS4LS is a delivery order under SPE2DB22D2214, an indefinite delivery contract.

Was contract SPE2DB25FS4LS competed?

The extent of competition for SPE2DB25FS4LS was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award